Volumetric modulated arc therapy versus intensity-modulated proton therapy in the irradiation of infra diaphragmatic Hodgkin Lymphoma in female patients

A recent study comparing IMRT versus IMPT for Hodgkin Lymphoma in female patients found that proton therapy may help reduce the risk of secondary cancer and fertility issues. Visit this link to access the article:

Volumetric modulated arc therapy versus intensity-modulated proton therapy in the irradiation of infra diaphragmatic Hodgkin Lymphoma in female patients

Keywords: Intensity-modulated proton therapy; RapidArc; VMAT; lymphoma; ovarian failure; secondary cancer risk estimate.

Mevion IMPT